Abstract
We have shown that inhibition of polyamine biosynthesis with α-difluoromethylornithine (DFMO) reduces in vitro invasiveness and metastatic capacity of MDA-MB-435 breast cancer cells. These experiments investigated the mechanisms mediating the anti-invasive properties of DFMO. DFMO did not affect phosphorylation of FAK or Akt, but increased ERK phosphorylation by approximately threefold. To test the biologic significance of this finding, we tested the effect of the MEK inhibitor PD98059 on in vitro invasiveness of MDA-MB-435 breast cancer cells, both in the absence and in the presence of the proinvasive peptide hepatocyte growth factor (HGF) as a chemoattractant. We observed that PD98059 treatment reversed the anti-invasive effect of DFMO under both experimental conditions. Next, we tested the influence of DFMO on the production of the prometastatic peptide osteopontin (OPN) and the anti-metastatic protein thrombospondin-1 (TSP-1). DFMO treatment, while not affecting OPN production, markedly increased the TSP-1 level in the conditioned media. This effect was abolished by putrescine administration, thus indicating the specificity of the DFMO action through the polyamine pathway. PD98059 completely blocked the stimulatory effect of DFMO on TSP-1 production, which supports a mediatory role for activation of the MAPK pathway in the upregulation of this anti-metastatic peptide by DFMO. In summary, our results show that the increase in ERK phosphorylation induced by DFMO plays a critical role in the anti-invasive action of the drug and in its ability to upregulate TSP-1 production.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Abbreviations
- ODC:
-
ornithine decarboxylase
- DFMO:
-
α-difluromethylornithine
- ERK:
-
extracellular signal-regulated kinase
- MAPK:
-
mitogen-activated protein kinase
- MEK-1:
-
MAP/ERK kinase-1
- OPN:
-
osteopontin
- TSP-1:
-
thrombospondin 1
- HGF:
-
hepatocyte growth factor
- FAK:
-
focal adhesion kinase
References
P Glikman A Manni L Demers M Bartholomew (1989) ArticleTitlePolyamine involvement in the growth of hormone-responsive and -resistant human breast cancer cells in culture. Clinical & Experimental Metastasis 49 1371–1376
KL Kendra BS Katzenellenbogen (1987) ArticleTitleAn evaluation of the involvement of polyamines in modulating MCF-7 human breast cancer cell proliferation and progesterone receptor levels by estrogen and antiestrogen. Clinical & Experimental Metastasis 28 123–128
A Manni R Grove S Kunselman M Aldaz (1995) ArticleTitleInvolvement of the polyamine pathway in breast cancer progression. Clinical & Experimental Metastasis 92 49–57
A Manni D Mauger P Gimotty B Badger (1996) ArticleTitlePrognostic influence on survival of increased ornithine decarboxylase activity in human breast cancer. Clinical & Experimental Metastasis 2 1901–1906
F Canizares J Salinas M las Heras Particlede et al. (1999) ArticleTitlePrognostic value of ornithine decarboxylase and polyamines in human breast cancer: correlation with clinicopathologic parameters. Clinical & Experimental Metastasis 5 2035–2041
A Manni S Washington JW Griffith MF Verderame D Mauger LM Demers et al. (2002) ArticleTitleInfluence of polyamines on in vitro and in vivo features of aggressive and metast behavior by human breast cancer cells. Clinical & Experimental Metastasis 19 95–105
A Manni S Washington L Craig et al. (2003) ArticleTitleEffects of alpha-difluoromethylornithine on local recurrence and pulmonary metastasis from MDA-MB-435 breast cancer xenografts in nude mice. Clinical & Experimental Metastasis 20 321–325
AB Tuck AF Chambers (2001) ArticleTitleThe role of osteopontin in breast cancer: clinical and experimental studies. Clinical & Experimental Metastasis 6 419–429
AB Tuck DM Arsenault FP O’Malley et al. (1999) ArticleTitleOsteopontin induces increased invasiveness and plasminogen activator expression of human mammary epithelial cells. Clinical & Experimental Metastasis 18 4237–4246
AB Tuck BE Elliott C Hota et al. (2000) ArticleTitleOsteopontin-induced, integrin-dependent migration of human mammary epithelial cells involves activation of the hepatocyte growth factor receptor (Met). Clinical & Experimental Metastasis 78 465–475
DL Weinstat-Saslow VS Zabrenetzky K VanHoutte WA Frazier DD Roberts PS Steeg (1994) ArticleTitleTransfection of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis. Clinical & Experimental Metastasis 54 6504–6511
JW Xuan C Hota AF Chambers (1994) ArticleTitleRecombinant GST-human osteopontin fusion protein is functional in RGD-dependent cell adhesion. Clinical & Experimental Metastasis 54 247–255
GN Hortobagyi (2001) ArticleTitleAdjuvant systemic therapy for early breast cancer: progress and controversies. Clinical & Experimental Metastasis 7 1839–1842
S Cowley H Paterson P Kemp CJ Marshall (1994) ArticleTitleActivation of MAP kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Clinical & Experimental Metastasis 77 841–852
S Traverse N Gomez H Paterson C Marshall P Cohen (1992) ArticleTitleSustained activation of the mitogen-activated protein (MAP) kinase cascade may be required for differentiation of PC12 cells. Clinical & Experimental Metastasis 288 351–355
RM Ray BJ Zimmerman SA McCormack TB Patel LR Johnson (1999) ArticleTitlePolyamine depletion arrests cell cycle and induces inhibitors p21(Waf1/Cip1), p27(Kip1), and p53 in IEC-6 cells Clinical & Experimental Metastasis 276 C684–C691
Y Chen K Alm S Vujcic DL Kramer K Kee P Diegelman et al. (2003) ArticleTitleThe role of mitogen-activated protein kinase activation in determining cellular outcomes in polyamine analogue-treated human melanoma cells. Clinical & Experimental Metastasis 63 3619–3625
A Manni R Wechter MF Verderame D Mauger (1998) ArticleTitleCooperativity between the polyamine pathway and HER-2neu in transformation of human mammary epithelial cells in culture: role of the MAPK pathway. Clinical & Experimental Metastasis 76 563–570
T Hawighorst H Oura M Streit L Janes L Nguyen LF Brown et al. (2002) ArticleTitleThrombospondin-1 selectively inhibits early-stage carcinogenesis and angiogenesis but not tumor lymphangiogenesis and lymphatic metastasis in transgenic mice. Clinical & Experimental Metastasis 21 7945–7956
LS Gutierrez M Suckow J Lawler VA Ploplis FJ Castellino (2003) ArticleTitleThrombospondin 1–a regulator of adenoma growth and carcinoma progression in the APC(Min/+) mouse model. Clinical & Experimental Metastasis 24 199–207
DJ Good PJ Polverini F Rastinejad MM Beau ParticleLe RS Lemons WA Frazier et al. (1990) ArticleTitleA tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Clinical & Experimental Metastasis 87 6624–6628
B Jimenez OV Volpert SE Crawford M Febbraio RL Silverstein N Bouck (2000) ArticleTitleSignals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1. Clinical & Experimental Metastasis 6 41–48
Y Yamashita T Kurohiji GP Tuszynski T Sakai T Shirakusa (1998) ArticleTitlePlasma thrombospondin levels in patients with colorectal carcinoma. Clinical & Experimental Metastasis 82 632–638
V Urquidi D Sloan K Kawai D Agarwal AC Woodman D Tarin et al. (2002) ArticleTitleContrasting expression of thrombospondin-1 and osteopontin correlates with absence or presence of metastatic phenotype in an isogenic model of spontaneous human breast cancer metastasis. Clinical & Experimental Metastasis 8 61–74
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Manni, A., Washington, S., Mauger, D. et al. Cellular mechanisms mediating the anti-invasive properties of the ornithine decarboxylase inhibitor α-difluoromethylornithine (DFMO) in human breast cancer cells. Clin Exp Metastasis 21, 461–467 (2004). https://doi.org/10.1007/s10585-004-2724-3
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10585-004-2724-3